Literature DB >> 3665007

Results of open heart surgery in patients with recent cardiogenic embolic stroke and central nervous system dysfunction.

Z Zisbrod1, D M Rose, I J Jacobowitz, M Kramer, A J Acinapura, J N Cunningham.   

Abstract

Patients undergoing open heart surgery who have had recent cardiogenic embolic stroke or have central nervous system dysfunction pose a difficult management problem. There is always the risk that cardiopulmonary bypass and heparinization may exacerbate the neurologic injury. There is no clear data indicating what is a safe interval of time from the onset of neurologic symptoms to the time of surgery. Since 1982 we have operated on 15 patients with recent (2 to 28 days, mean 12.7 +/- 7.9 days) neurologic injury. Indications for surgery included recurrent embolization, sepsis, and hemodynamic deterioration. Three patients were comatose with no focal neurologic signs at the time of surgery, and 12 patients had focal neurologic deficits. All patients had preoperative computed tomographic scans. Embolic cerebral infarctions were documented in 12 patients, one patient had evidence of intracranial hemorrhage, and one patient had a subdural hematoma. Fourteen patients had native or prosthetic valvular endocarditis and one patient had a left atrial myxoma. All patients underwent corrective cardiac surgery. One patient died in the postoperative period from multisystem failure; all other patients have been followed since discharge (6 months to 4 years). All surviving patients demonstrated improvement in their neurologic symptoms and eight patients had complete neurologic recovery. The results of this study indicate that open heart surgery can be safely performed in patients with recent neurologic injury.

Entities:  

Mesh:

Year:  1987        PMID: 3665007

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Early versus Delayed Surgery.

Authors:  Gwan Sic Kim; Joon Bum Kim; Sung-Ho Jung; Tae-Jin Yun; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-10-06

Review 2.  What is the optimal timing for surgery in infective endocarditis with cerebrovascular complications?

Authors:  Michele Rossi; Alina Gallo; Ravi Joseph De Silva; Rana Sayeed
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-18

3.  Timing the valve replacement in infective endocarditis involving the brain.

Authors:  Klemens Angstwurm; Adrian C Borges; Elke Halle; Eva Schielke; Karl M Einhäupl; Joerg R Weber
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

4.  Successful surgical management of patients with infective endocarditis associated with acute neurologic deficits.

Authors:  Yoshihiro Sawamura; Takeo Fukuju; Sekinori Kikuchi; Masakazu Kitahara; Takashi Ito; Koichi Tabayashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-05

5.  Left atrial free-floating ball thrombus with recent cardioembolic stroke.

Authors:  Nanritsu Matsuyama; Toshihiro Kodama; Naoki Wada; Shigeto Hasegawa; Kunio Asada; Shinjiro Sasaki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-01

6.  [Emergency heart valve replacement after acute cerebral embolism during florid endocarditis].

Authors:  D Horstkotte; C Piper; M Wiemer; G Arendt; H Steinmetz; R Bergemann; H D Schulte; H P Schultheiss
Journal:  Med Klin (Munich)       Date:  1998-05-15

7.  Giant left atrial myxoma - literature review and case presentation.

Authors:  Victor Cornel Raicea; Horaţiu Suciu; Andrei Dan Raicea; Gheorghe Cosmin Macarie; Tibor Mezei; Maria Smaranda Maier
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

8.  Cardiac Myxoma and Cerebrovascular Events: A Retrospective Cohort Study.

Authors:  Maria-Ioanna Stefanou; Dominik Rath; Vera Stadler; Hardy Richter; Florian Hennersdorf; Henning F Lausberg; Mario Lescan; Simon Greulich; Sven Poli; Meinrad P Gawaz; Ulf Ziemann; Annerose M Mengel
Journal:  Front Neurol       Date:  2018-10-03       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.